Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population

PHASE3TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Labor, Premature
Interventions
DRUG

Magnesium

Intravenous Magnesium 6 gram load, 3 grams/hr

DRUG

Nifedlipine

Oral Nifedpine 10 mgs q 20 min to effect (max 40mgs)...then 20 mgs q 4hrs

Trial Locations (1)

92806

Memorial Care Center for Women/Long Beach Memorial Medical Center, Long Beach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MemorialCare

OTHER

NCT00641784 - Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population | Biotech Hunter | Biotech Hunter